Table 4.
Comparison of quantification levels of anti-PLA2R antibodies among three groups before treatment
| Groups | n | Quantification levels of anti-PLA2R antibodies (RU/mL) |
|---|---|---|
| Complete remission group | 16 | 122.31±71.98 |
| Partial remission group | 24 | 198.11±219.00 |
| Non-remission group | 16 | 483.42±630.48a,b |
| F | 6.404 | |
| P | 0.002 |
Notes: Before treatment: non-remission group compared with complete remission group,
a
P<0.05; non-remission group compared with the partial remission group,
b
P<0.01. Before treatment, the serum levels of anti-PLA2R antibodies in the non-remission group were significantly higher than those in the complete remission group and partial remission group.